Lifesparc
Payments companies reported to CMS as associated with Lifesparc. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lifesparc, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lifesparc
These are the largest totals companies reported as associated with Lifesparc. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Raymond Yau | Albuquerque, NM | Interventional Cardiology | $40,417.49 |
| Sandeep Patel | Lima, OH | Cardiovascular Disease | $23,948.01 |
| Yasin Khan | New Orleans, LA | Pulmonary Disease | $11,058.49 |
| Rajan Patel | New Orleans, LA | Interventional Cardiology | $10,779.32 |
| Karl Kern | Tucson, AZ | Cardiovascular Disease | $9,432.50 |
| Gabriel Hernandez | Jackson, MS | Internal Medicine | $8,370.87 |
| Joshua Smith | Birmingham, AL | Anesthesiology | $8,062.36 |
| I-Hui Chiang | Mesa, AZ | Interventional Cardiology | $7,497.96 |
| Daniel Lo Verde | Greenville, SC | Pulmonary Disease | $7,353.00 |
| Navin Kapur | Baltimore, MD | Cardiovascular Disease | $7,335.30 |
Prescribed Lifesparc?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.